Is Cardinal Health (CAH) Undervalued On Strong Earnings Expectations?

Cardinal Health (CAH) is currently considered undervalued by Simply Wall St's narrative, with a fair value of $250.53 against its last close of $236.40, driven by strong earnings expectations and revenue growth. However, the market's P/E ratio for CAH suggests it trades higher than the US Healthcare sector and its own fair ratio, indicating less room for error. Investors are advised to consider potential risks like government pricing pressures and customer contract changes despite the optimistic outlook.